Carnegie Investment Bank

Occlutech, founded in 2003, is a rapidly expanding European hi-tech company specializing in developing and manufacturing cardiac occlusion devices and other vascular implants. The company has developed several new, unique products using a wide range of state of the art technological capabilities and proprietary know-how.

Doktor.se is a modern and personal care company working with digital healthcare. They are in an expansive phase, they have several offices in Sweden and grow sharply. With experienced specialist nurses, doctors and psychologists, they help their members to get quick and effective care. Their goal is to deliver a whole new level of service within Swedish care. They help with counseling, book doctor hours, distance care, recipes, referrals, and much more. They always follow every case through their app. They also provide exclusive care and health offers as well as collecting interesting articles and news that will suit the clients. Doktor.se is an approved healthcare provider its counseling and booking are carried out by certified healthcare professionals and specialists in their area. Doktor.se also owns physical primary care and has extensive experience in Swedish healthcare.

Doktor.se is a modern and personal care company working with digital healthcare. They are in an expansive phase, they have several offices in Sweden and grow sharply. With experienced specialist nurses, doctors and psychologists, they help their members to get quick and effective care. Their goal is to deliver a whole new level of service within Swedish care. They help with counseling, book doctor hours, distance care, recipes, referrals, and much more. They always follow every case through their app. They also provide exclusive care and health offers as well as collecting interesting articles and news that will suit the clients. Doktor.se is an approved healthcare provider its counseling and booking are carried out by certified healthcare professionals and specialists in their area. Doktor.se also owns physical primary care and has extensive experience in Swedish healthcare.

We believe the time is right to expand chemical recycling, giving post-use plastic a new, circular life by converting this valuable material back into its original building blocks for reuse. By enabling plastic circularity on a global and commercial scale, we aim to play a vital role in accelerating the shift to a low-carbon economy. We have co-founded Cyclyx International, Inc, a waste plastics management company, to work directly with industry participants to engineer customized plastic recovery programs that supply advanced and chemical recycling facilities.

Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focusing on the development and marketing of innovative pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases. This area of high unmet medical need includes many orphan and niche indications with no current therapy.

Genizon Biosciences Inc. discovers genes and biomarkers in common diseases using genome wide association studies (GWAS), leveraging its proven and proprietary technology platform and access to patients from the Quebec Founder Population.

Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focusing on the development and marketing of innovative pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases. This area of high unmet medical need includes many orphan and niche indications with no current therapy.

Genizon Biosciences Inc. discovers genes and biomarkers in common diseases using genome wide association studies (GWAS), leveraging its proven and proprietary technology platform and access to patients from the Quebec Founder Population.

Galileo genomics is a Montreal-based private genetics company that conducts research in Quebecers of French descent using cutting-edge technologies, to identify genes that cause disease, thus providing validated targets for creation of innovative and more effective therapies and diagnostics. The Quebec founder population is the largest such population worldwide, which facilitates rapid patient recruiting. Because of the relatively late founding of the population in the 17th century, the relatively small number of founders, rapid early population growth, minimal intermarriage with other groups, and loss of some family lines while others expanded dramatically, the population is among the most homogeneous and has among the highest genetic sharing of all major founder populations.

Agensys a biotechnology company, engages in the research and development of therapeutic human monoclonal antibodies and antibody drug conjugates for the treatment of cancer. It offers products to treat various tumors, as well as prostate, pancreatic, and bladder cancers. The company, formerly known as UroGenesys, was founded in 1997 and is based in Santa Monica, California. As of December 18, 2007, Agensys, Inc. operates as a subsidiary of Astellas Pharma US, Inc.

ZoomON's software enables anyone with a browser to view, mark-up, design and collaborate on complex, and simple, graphics. This includes maps, product drawings and product catalogs. Their software cuts across proprietary technologies and unleashes the details anytime, anywhere!